Events

Dec 11 2024
11:30 AM EST
Upcoming

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day

Nov 22 2024
8:30 PM - 10:30 PM EST
Archived

Update on a Potentially Pivotal Trial CNS-201: A Randomized, Controlled Trial of Berubicin Vs. Lomustine After First-Line Therapy for Glioblastoma Multiforme (GBM)

Sep 09 2024
7:00 AM EDT
Archived

CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 03 2024
12:00 AM EDT
Archived

BioMedWire Podcast

Aug 28 2024
10:56 PM EDT
Archived

LIVE! with Webull Corporate Connect: Biotech Investment Webinar

Aug 26 2024
12:00 PM EDT
Archived

Virtual Investor CEO Connect Segment

Jul 30 2024
8:30 AM EDT
Archived

CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Blood Brain Barrier Permeable Taxane for Treatment of Brain Malignancies

Apr 30 2024
3:00 PM EDT
Archived

Annual Meeting of Stockholders

There are no events that match the selected filters.
View More
Stay Updated
At least one type of alert must be selected.
An email address is required.

Your email alerts were set.

The following alerts could not be set: